Executive summary. Slow-moving inventory ties up cash and builds expiry risk, even when every item was bought for a sensible reason.
Definition
Slow-moving inventory is stock that is used or sold less quickly than expected.
Where this work lives in Attergo
Margin dashboards, Item Costs, Cost Sources, Payer Contracts, and Payer Scorecards sit beside one another in Attergo, so purchasing and finance leads can read the figures together. Open the supporting record behind any number that looks wrong, note the question, and take it into the next conversation with the supplier or the payer.
Some medications sit on the shelf because they are clinically important, seasonal, or hard to obtain. Others sit there because demand moved. Separate the two before anyone concludes that an item was ordered badly.
Review and follow up
Review quantities, expiry dates, patient need, and supplier return options together at regular intervals. When reducing stock, check that the decision does not create an access problem for the patients who depend on that medication.
Final decisions stay with the role your organization holds accountable for them. Record the decision on the item, with the evidence behind it, so the next person to open it does not start over.
Frequently asked questions
Who should use this Attergo workspace?
The role that owns the next action leads it: a billing specialist, an authorization coordinator, an inventory lead, a pharmacist, a compliance lead, or a finance reviewer. Access follows the role your organization assigns.
Referenced standards and further reading
- FDA: Drug shortages ↗U.S. Food and Drug Administration
Related articles
Acquisition cost is evidence with a date on it →